Light sensor may spot kidney trouble during liver transplants
NCT ID NCT07409532
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a non-invasive light sensor (near-infrared spectroscopy) placed on the skin over the kidney could measure oxygen levels during liver transplant surgery. Researchers monitored 41 patients to see if this method gives useful information about kidney function compared to standard tests. The goal was to find a better way to detect kidney problems early during surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
41 people
The number who actually took part.
- Started
-
Dec 2022
- Finished
-
Aug 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients undergoing elective liver transplantation between the ages of 18 and 65
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
This prospective observational study was conducted at the Inönü University Liver Transplant Institute between 2022 and 2023, following approval by the Malatya Clinical Research Ethics Committee (Approval No. 2022/118). Inclusion Criteria: * Patients aged 18-65 scheduled for elective liver transplantation. * American Society of Anesthesiologists (ASA) physical status III-IV were enrolled. Exclusion Criteria: * Patients undergoing emergency liver transplantation, * Advanced preexisting renal dysfunction * İndividuals with significant cardiovascular instability
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for End-stage liver disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Inonu University Liver Transplant Institute
Malatya, 44280, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can better training get doctors to talk about what matters most to dying veterans?
- Can a Once-Daily form of tacrolimus spare liver transplant patients from side effects?
- Could a mask replace the breathing tube in liver transplants?
- Can immune cells predict herpesvirus danger in transplant patients?
- Can a helping hand ease the burden of pediatric liver transplants?
- Can a helping hand ease the leap to adult transplant care?